NASDAQ:IOVA

Iovance Biotherapeutics Stock Predictions

etoro logo Buy IOVA
*Your capital is at risk
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

IOVA Prediction Chart

IOVA Predictions History

Latest community submissions for IOVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 5, 2025 $2.70 -4.72% $2.75 V 98.06% 1
Aug 5, 2025 $2.91 +2.95% $2.75 X 94.06% 0
Aug 5, 2025 Bullish $2.75 V 0
Jul 31, 2025 Bullish $2.57 X 0
Jul 18, 2025 Bullish $2.23 X 0
Jun 30, 2025 Bullish $1.72 V 1
Jun 18, 2025 $2.07 +2.35% $2.04 V 98.65% 2
Jun 18, 2025 Bullish $2.04 X 1
Jun 11, 2025 $2.30 -3.38% $2.24 V 97.34% 1
Jun 11, 2025 $2.33 -2.11% $2.24 V 96.00% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IOVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE